On this episode of Transforming Biopharma, Maria Whitman hears from Josette Gbemudu, executive director of health equity and social determinants of health at Merck, about how the company is taking action to make its vision of health equity a reality. They also discuss opportunities for biopharma to cooperatively tackle the barriers to systemic change. Highlights:How Merck is mobilizing and empowering teams to create momentum around health equity Why trust is an equity issue The power of industry-wide collaboration in creating change—and why it’s critical to measure progress